Providing Relief to Debilitating Mental Illness

OUR DEVELOPMENT PROGRAMMES ARE UNDERLINED BY EXCELLENT SCIENCE TO BRING SAFE AND EFFECTIVE DRUGS TO OUR PATIENTS WHILE CREATING THE HIGHEST VALUE FOR OUR SHAREHOLDERS

Product Pipeline

Our product pipeline comprises small molecules being developed for CNS indications are currently in pre-clinical and clinical stages.

R&D Disease Areas

Research and development to address unmet medical needs in Central Nervous System diseases.

Drug Development

Development of new drug molecules for the benefit of patients suffering from mental disorders.